Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)

Abstract Background Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long ter...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alberto M. Marra, Michael Halank, Nicola Benjamin, Eduardo Bossone, Antonio Cittadini, Christina A. Eichstaedt, Benjamin Egenlauf, Satenik Harutyunova, Christine Fischer, Henning Gall, Hossein Ardeschir Ghofrani, Marius M. Hoeper, Tobias J. Lange, Karen M. Olsson, Hans Klose, Ekkehard Grünig
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2018-12-01
coleção:	Respiratory Research
Assuntos:	Pulmonary hypertension Pulmonary arterial hypertension Chronic thromboembolic pulmonary hypertension Riociguat Soluble guanylate cyclase stimulator Right atrial area
Acesso em linha:	http://link.springer.com/article/10.1186/s12931-018-0957-y
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!